Vernon Rogers, who serves as Executive Vice President of Sales & Marketing at AEHR Test Systems (NASDAQ:AEHR), executed an insider sale on April 20, 2026, disposing of 5,000 shares of the company's common stock at $90.00 per share. The trade produced gross proceeds of $450,000.
After the transaction, Mr. Rogers retains direct ownership of 147,716 AEHR common shares. That total includes shares that remain subject to unvested restricted stock units, as reported by the company.
Investors seeking additional analysis of AEHR’s valuation or operating performance can consult a comprehensive Pro Research Report that the company has made available for this and more than 1,400 other U.S. equities.
AEHR Test Systems has recently pursued multiple financing and commercial milestones. The company completed an at-the-market equity program that raised $60 million under an effective registration statement. That offering allowed AEHR to sell common stock into the market to raise capital.
Separately, AEHR reported securing a production order valued at $41 million from a hyperscale customer, the largest order in the company’s history. The order is for AI chip testing equipment, including high-power test systems designed to support AI workloads in data centers. AEHR expects deliveries on this production order to begin in fiscal 2027.
Market analysts adjusted their stances following these developments. Freedom Broker increased its price target on AEHR to $61, citing robust demand indicators despite a small revenue shortfall in the third quarter of fiscal 2026. AEHR reported $10.3 million in revenue for Q3 FY26, marginally under the $10.8 million consensus estimate, while achieving record bookings of $37.2 million for the period.
Lake Street also raised its price target, to $56, pointing to continued bookings momentum and a book-to-bill ratio above 3.5x. Both firms highlighted the strength of order intake as a central factor in their revised outlooks.
Taken together, the insider sale by Mr. Rogers, the $60 million at-the-market financing, and the record $41 million production order represent a cluster of corporate actions that investors and market observers will likely monitor closely. The production order ties AEHR directly to demand for AI-focused testing infrastructure in large-scale data center environments, while the equity offering provides additional liquidity to support the company’s operations and growth plans.